Advertisement

Topics

Catalyst Advisors, L.P. Company Profile

15:32 EDT 19th April 2018 | BioPortfolio

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate critical inflection points in the corporate trajectory. The firm has offices in New York, London and Los Angeles. For more information, please visit www.catalystadvisorslp.com and follow Catalyst Advisors, L.P. on LinkedIn.


News Articles [740 Associated News Articles listed on BioPortfolio]

Health IT Experts Join Health Catalyst Team

David RathsSalt Lake City-based healthcare data analytics company Health Catalyst has added three health IT and quality heavyweights as strategic advisors.

InvestmentNews Names Miracle Mile Advisors Among Top 50 Best Places to Work for Financial Advisors

"I wanted to build a firm where everyone looks forward to Mondays, and advisors could provide meaningful, incomparable advice," said Brock Moseley, founder of Read more...

Efficient Advisors To Offer Dimensional Funds

Efficient Advisors' investment philosophy aligns well with Dimensional's. Efficient Advisors deploys a disciplined, diversified, low-cost investment strategy focusing on factors that research shows ...

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

Catalyst eyes 2018 filing for rare disease drug candidate

Positive data from a second Phase 3 study has Catalyst on track to resubmit Firdapse for potential U.S. approval.

In The Spotlight: Catalyst Biosciences

Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

Drugs and Medications [0 Results]

None

PubMed Articles [463 Associated PubMed Articles listed on BioPortfolio]

Do People Inherently Dislike Uncertain Advice?

Research suggests that people prefer confident to uncertain advisors. But do people dislike uncertain advice itself? In 11 studies ( N = 4,806), participants forecasted an uncertain event after receiv...

What do physiotherapists and manual handling advisors consider the safest lifting posture, and do back beliefs influence their choice?

It is commonly believed lifting is dangerous and the back should be straight during lifting. These beliefs may arise from healthcare professionals, yet no study has evaluated the lifting and back beli...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

A solid iridium catalyst for diastereoselective hydrogenation.

An Ir(NHC) supported catalyst is used in the selective hydrogenation of terpinen-4-ol to cis p-menthan-4-ol. Its activity, selectivity and stability are compared to those of a homogeneous homologue [I...

Plasma-catalyst hybrid reactor with CeO2/γ-Al2O3 for benzene decomposition with synergetic effect and nano particle by-product reduction.

A dielectric barrier discharge (DBD) catalyst hybrid reactor with CeO2/γ-Al2O3 catalyst balls was investigated for benzene decomposition at atmospheric pressure and 30 °C. At an energy density of ...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Lay Health Advisors for Sexually Transmitted Disease Prevention

Non-professional community leaders may be at a great advantage in reaching otherwise hard to reach populations for the purpose of advising on sexually transmitted disease (STD) prevention ...

Trial of Health at Work Workplace Health Intervention

This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wi...

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Telehealth Depression Treatments for Older Adults

This study aims to find an effective and sustainable approach to reducing disparities in accessing mental health services for an underserved and growing population group of low-income, rac...

Collaboration to Improve Blood Pressure in the US Black Belt-addressing the Triple Threat

The central objective of this proposal is to rigorously compare two strategies designed to improve BP control in primary care practices serving rural Southeastern African Americans with lo...

Companies [325 Associated Companies listed on BioPortfolio]

Catalyst Advisors, L.P.

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate cr...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Clearsight Advisors

Clearsight Advisors is an independent merchant banking firm dedicated to providing world-class M&A and capital raising solutions exclusively to growth-oriented Business Services a...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

More Information about "Catalyst Advisors, L.P." on BioPortfolio

We have published hundreds of Catalyst Advisors, L.P. news stories on BioPortfolio along with dozens of Catalyst Advisors, L.P. Clinical Trials and PubMed Articles about Catalyst Advisors, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Advisors, L.P. Companies in our database. You can also find out about relevant Catalyst Advisors, L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record